Mesothelioma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a personal history of any cancer and it is known or suspected that you carry a specific inherited gene change involving a gene called BAP1
- Or, you are a close blood relative (parent, child, sibling, grandparent, aunt/uncle, or first cousin) of someone who has been confirmed to have a condition called BAP1 Tumor Predisposition Syndrome (a hereditary condition linked to certain cancers), whether or not you yourself have had cancer
- You are 30 years of age or older
- You are willing and able to read and sign a consent form agreeing to take part in the study
- For the monitoring/surveillance part of the trial: you have already completed the genetic testing step of this study and were found to carry a BAP1 or related inherited gene change
- For the monitoring/surveillance part of the trial: you are also enrolled in a related study at the same institution (confirm with trial site)
Who may not be able to join:
- No specific exclusion criteria were listed in the official criteria provided (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David S Schrump, M.D., National Cancer Institute (NCI)
Phone: (240) 781-4037
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prospectively gather information related to the use of dual energy computed tomographic imaging (DECT) together with minimally invasive surveillance for early detection of mesotheliomas in patients with BAP1 TPDS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.